1. Recurrent Pontine Strokes in a Young Male
- Author
-
Horst Urbach, Sebastian Paus, and Marcus Grobe-Einsler
- Subjects
Male ,genetics [Leukoencephalopathies] ,Pontine stroke ,CADASIL ,Leukoencephalopathy ,0302 clinical medicine ,Recurrence ,therapy [Cerebral Small Vessel Diseases] ,Medicine ,therapy [Brain Stem Infarctions] ,genetics [Collagen Type IV] ,Stroke ,diagnostic imaging [Brain Stem Infarctions] ,PADMAL ,Rehabilitation ,blood supply [Pons] ,medicine.anatomical_structure ,Cardiology ,Disease Progression ,diagnostic imaging [Leukoencephalopathies] ,diagnostic imaging [Cerebral Small Vessel Diseases] ,Cardiology and Cardiovascular Medicine ,Vasculitis ,Adult ,Collagen Type IV ,medicine.medical_specialty ,COL4A1 ,Central nervous system ,physiopathology [Brain Stem Infarctions] ,03 medical and health sciences ,Internal medicine ,Humans ,Genetic Predisposition to Disease ,ddc:610 ,physiopathology [Cerebral Small Vessel Diseases] ,physiopathology [Leukoencephalopathies] ,business.industry ,Microangiopathy ,COL4A1 protein, human ,medicine.disease ,Pons ,Hyperintensity ,genetics [Brain Stem Infarctions] ,therapy [Leukoencephalopathies] ,Mutation ,genetics [Cerebral Small Vessel Diseases] ,Surgery ,Neurology (clinical) ,Hereditary stroke ,business ,030217 neurology & neurosurgery - Abstract
A 34-year-old patient presented to the emergency department with recurrent neurologic symptoms of sudden onset. MRI showed white matter hyperintensities consistent with small vessel disease, predominantly in the pons. There were no known cardiovascular risk factors (CVRF) and extensive workup for vasculitis was negative. The preliminary diagnosis was small vessel primary central nervous system vasculitis, but immunosuppressive treatment did not stop a progression of the disease over 6 months. Repeated negative diagnostic workup for vasculitis, lack of response to therapy, young age, and predominant involvement of the pons were compatible with pontine autosomal dominant microangiopathy and leukoencephalopathy (PADMAL), which is a very rare monogenic cause of cerebral small vessel disease due to upregulation of collagen type-IV. Correspondingly, a COL4A1 mutation was found. Therapy was immediately stopped in favour of more strict adjustment of the CVRF including lowering of LDL < 70 mg/dl and extensive monitoring of blood-pressure.
- Published
- 2020
- Full Text
- View/download PDF